BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38685520)

  • 21. Peli1 Modulates the Subcellular Localization and Activity of Mdmx.
    Li D; Tavana O; Sun SC; Gu W
    Cancer Res; 2018 Jun; 78(11):2897-2910. PubMed ID: 29523541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
    Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The E3 ubiquitin ligase Peli1 regulates the metabolic actions of mTORC1 to suppress antitumor T cell responses.
    Ko CJ; Zhang L; Jie Z; Zhu L; Zhou X; Xie X; Gao T; Yang JY; Cheng X; Sun SC
    EMBO J; 2021 Jan; 40(2):e104532. PubMed ID: 33215753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
    Xu Y; Feng Y; Sun Z; Li Q
    Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
    Chen H; Luo Q; Li H
    Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
    Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
    Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peli1 negatively regulates noncanonical NF-κB signaling to restrain systemic lupus erythematosus.
    Liu J; Huang X; Hao S; Wang Y; Liu M; Xu J; Zhang X; Yu T; Gan S; Dai D; Luo X; Lu Q; Mao C; Zhang Y; Shen N; Li B; Huang M; Zhu X; Jin J; Cheng X; Sun SC; Xiao Y
    Nat Commun; 2018 Mar; 9(1):1136. PubMed ID: 29555915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination.
    Liu S; Liu P; Zhu C; Yang R; He Z; Li Y; Li Y; Fei X; Hou J; Wang X; Pan Y
    Aging (Albany NY); 2023 Jun; 15(12):5381-5398. PubMed ID: 37348029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol-derived inhibitors of the E3 ubiquitin ligase PELI1 inhibit the metastasis of triple-negative breast cancer.
    Xu G; Zhou Q; Qi J; Li Z; Yin L; Li Z; Lu C; Zhao B; Shen Y
    Eur J Med Chem; 2024 Feb; 265():116060. PubMed ID: 38150964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation.
    Cai X; Gao J; Yan Z; Zhang H; Guo D; Zhang S
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):303. PubMed ID: 38861187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CHIP is a novel tumor suppressor in pancreatic cancer through targeting EGFR.
    Wang T; Yang J; Xu J; Li J; Cao Z; Zhou L; You L; Shu H; Lu Z; Li H; Li M; Zhang T; Zhao Y
    Oncotarget; 2014 Apr; 5(7):1969-86. PubMed ID: 24722501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination.
    Jeon YK; Kim CK; Hwang KR; Park HY; Koh J; Chung DH; Lee CW; Ha GH
    Cell Death Differ; 2017 Mar; 24(3):469-480. PubMed ID: 28009353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E3 Ubiquitin Ligase MARCH8 Promotes Pancreatic Cancer Growth and Metastasis by Activating STAT3 via Degradation of PTPN4.
    Chen C; Wang Y; Zhao Q; Li GD; Wang YH; Xu LC; Huang HZ; Song G; Li WT; He XH
    Pancreas; 2023 Apr; 52(4):e224-e234. PubMed ID: 37747937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.
    Xu H; Ju L; Xiong Y; Yu M; Zhou F; Qian K; Wang G; Xiao Y; Wang X
    Cell Death Dis; 2021 Mar; 12(3):239. PubMed ID: 33664240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
    Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
    Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway.
    Meng LD; Shi GD; Ge WL; Huang XM; Chen Q; Yuan H; Wu PF; Lu YC; Shen P; Zhang YH; Cao SJ; Miao Y; Tu M; Jiang KR
    Cancer Lett; 2020 Dec; 494():107-120. PubMed ID: 32814086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
    Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
    Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
    Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.